HLB Pharmaceutical Co (XKRX:047920) Other Income (Expense) : ₩1,521 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Other Income (Expense)?

HLB Pharmaceutical Co's other income expense for the HLB Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ₩-465 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩1,521 Mil.

HLB Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for HLB Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Other Income (Expense) Chart

HLB Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-81,059.09

2,265.01

208.35

12,054.73

-117.13

HLB Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															-2,817.20	-50.19	144.16	1,892.46	-465.49

HLB Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,521 Mil.

HLB Pharmaceutical Co (XKRX:047920) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

HLB Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Other Income (Expense)

Traded in Other Exchanges

N/A

Address

67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR

Website

http://www.hlbpharma.co.kr

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines